首页> 美国卫生研究院文献>World Journal of Gastroenterology >P21 and CEA expression and AgNOR counts in dimethylhydrazine-induced colon carcinoma in rats
【2h】

P21 and CEA expression and AgNOR counts in dimethylhydrazine-induced colon carcinoma in rats

机译:P21,CEA在二甲基肼诱发的大鼠结肠癌中的表达及AgNOR计数

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To study P21 and carcinoembryonic antigen (CEA) expression and to measure argyrophilic nucleolar organizer region (AgNOR) counts in various lesions of colonic mucosa and the mechanism of carcinogenesis.METHODS: Thirty-eight male Wistar rats were injected with dimethylhydrazine (DMH) once a week for 25 wk. P21 and CEA expression was detected by immunohistochemical methods, and AgNOR was counted by silver staining paraffin sections from various colonic lesions.RESULTS: The incidence of colonic carcinoma in DMH-treated rats was 71.05% (27/38), and lymph node metastasis occurred in six rats. Immunohistochemical studies showed that P21 was primarily expressed in dysplasia and carcinomas, while CEA was expressed in carcinomas and metastatic tumors. AgNOR counts were higher in dysplasia and carcinomas. There were significant differences in P21 and CEA expression between benign and malignant lesions (P < 0.05). The difference in AgNOR counts was also significant between normal and dysplastic tissues, and between dysplasia and malignant lesions (P < 0.05).CONCLUSION: Dysplasia is a premalignant change of colonic carcinoma. The detection of P21 via immunohistochemistry and AgNOR counting may be an important clinical screening technique for colon carcinoma and premalignant lesions.
机译:目的:研究P21和癌胚抗原(CEA)的表达,并测定结肠粘膜各种病变中嗜银核仁组织区(AgNOR)的数量及其致癌机理。方法:对38只雄性Wistar大鼠注射二甲基肼(DMH)。每周一次,每周25周。免疫组化法检测P21和CEA的表达,并用银染石蜡切片对不同结肠病变进行AgNOR计数。结果:DMH治疗大鼠结肠癌的发生率为71.05%(27/38),并有淋巴结转移在六只老鼠中。免疫组织化学研究表明,P21主要在不典型增生和癌中表达,而CEA在癌和转移性肿瘤中表达。在异型增生和癌中,AgNOR计数较高。良性和恶性病变之间的P21和CEA表达存在显着差异(P <0.05)。正常组织和增生组织之间以及异常增生和恶性病变之间的AgNOR计数差异也很显着(P <0.05)。结论:不典型增生是结肠癌的癌前变化。通过免疫组织化学和AgNOR计数检测P21可能是结肠癌和癌前病变重要的临床筛查技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号